Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest National Institute for Health and Clinical Excellence Stories

2008-09-01 12:00:20

DR McGONAGLE'S put-down of NICE (Letters, August 28) as the "National Institute of Complete Embarrassment" does a disservice. NICE has produced final guidance for the drug Lucentis, now accepted for use throughout the UK. It slows age-related macular degeneration (AMD) which gradually destroys central vision, making reading or driving difficult or impossible. This is clearly not a trivial problem - but neither are the processes required to ensure fairness when deriving priorities for use...

2008-08-28 06:01:10

The National Institute for Health and Clinical Excellence has recommended Novartis's Lucentis as a cost-effective therapy for all eligible patients with wet age-related macular degeneration. The announcement is said to be an important development for patients because the National Institute for Health and Clinical Excellence (NICE) determines access to medicines in England and Wales based on agreed standards of cost-effectiveness. The final guidance comes at the end of a rigorous review...

2008-08-28 00:00:38

By Paul Greaves A war veteran who fought a campaign to get a sight-saving drug on the NHS says he feels "vindicated" it will now be made freely available across the country. The National Institute for Health and Clinical Excellence (Nice) has recommended the drug Lucentis be provided free of charge to people with wet age-related macular degeneration (AMD). Former pilot Jack Tagg, 88, from Torquay, Devon, visited Downing Street earlier this year to protest about a decision by his local...

2008-08-28 00:00:37

By JULIA BRADSHAW People who face going blind will now have access to a sight- saving drug on the NHS following a massive campaign to make the medication more widely available. The National Institute for Health and Clinical Excellence has today published guidelines instructing primary care trusts in England and health boards in Wales to fund the drug Lucentis for patients who have wet age- related macular degeneration in either eye. But patients across Devon have already been...

2008-08-27 06:00:48

By Mike Waites Health Correspondent The National Institute for Clinical Excellence (Nice) has backed NHS treatment using the drug Lucentis for the devastating eye condition wet age-related macular degeneration (AMD) following a two- and-half-year battle by patients.The Yorkshire Post revealed last month that people affected by the condition in the region are already being treated using the drug but the decision means the national postcode lottery of care will now end.The disease is the...

2008-08-27 00:00:44

By Jane Kirby Thousands OF people with a devastating eye disease could have their sight saved by a new drug being made available on the NHS, under guidelines published today. The National Institute for Health and Clinical Excellence (Nice) has recommended the drug Lucentis, which is already approved in Scotland, after performing a u-turn on draft guidance published last year. The move was welcomed by the Royal National Institute for the Blind (RNIB), which has campaigned for Lucentis...

2008-08-26 18:00:48

By Emma Brady Midlands cancer patients are being kept in the dark about new treatments that could extend their lives, it was claimed today. One in four myeloma specialists questioned in a survey admitted hiding facts about new treatments that may be tough to obtain on the NHS, citing the main reason was to avoid upsetting or confusing patients. The Myeloma UK poll comes less than three weeks after the National Institute for health and Clinical Excellence (Nice) issued draft guidance...

2008-08-26 18:00:00

By John von Radowitz DOCTORS are keeping cancer patients in the dark about new treatments that could extend their lives, it was claimed today. A quarter of myeloma specialists questioned in a survey admitted hiding the facts about treatments that may be difficult to obtain on the NHS. The main reason given was to avoid distressing or confusing patients. Myeloma is a bone marrow cancer that affects around 3,800 people each year in the UK. Of these, 2,600 are likely to die from the...

2008-08-26 03:00:56

A Cautious welcome has been given to a pledge by Assembly Health Minister Edwina Hart to call on her officials to ensure Welsh rheumatoid arthritis patients get effective treatment. Jenny Randerson, Lib Dem Assembly health spokeswoman, said she was pleased with the vow after flagging up concerns about new guidance on limiting drug treatments to "one go only". Although a number of drugs are on offer to deal with the condition, the draft guidance from Nice (the National Institute for...

2008-08-25 09:00:26

Leading UK cancer experts have accused a health watchdog of forcing patients to remortgage their homes to afford treatments freely available in Europe. The group of 26 professors were "dismayed" at guidance issued by the National Institute for Health and Clinical Excellence (Nice) to deny patients four vital kidney cancer drugs on the NHS. They said the decision showed it was time for a "radical change" in how the NHS makes decisions on what treatments are available for cancer sufferers....